C07D 203/10

Technology



back to "C07D 203/10" profile

More Results

Patent/Pub #TitleFiling DateIssue/Publication DatePatent Owner
9822058 Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereofMar 13, 13Nov 21, 17CHDI FOUNDATION, INC.
9707292 Lipids and compositions for the delivery of therapeuticsOct 15, 15Jul 18, 17ARBUTUS BIOPHARMA CORPORATION
9682139 Lipids and compositions for the delivery of therapeuticsFeb 24, 15Jun 20, 17ARBUTUS BIOPHARMA CORPORATION
9365510 Aziridine bisphenol ethers and related compounds and methods for their useApr 16, 13Jun 14, 16BRITISH COLUMBIA CANCER AGENCY BRANCH, THE UNIVERSITY OF BRITISH COLUMBIA,
9249109 Method for preparing dipeptidyl peptidase-IV inhibitor and intermediateOct 03, 14Feb 02, 16DONG-A PHARM. CO., LTD.
9187419 Intermediates of sitagliptin and preparation process thereofDec 01, 11Nov 17, 15Zhejiang Hisoar Pharmaceutical Co., Ltd
8871950 Process for preparing (+)-polyoxamic acidOct 29, 13Oct 28, 14KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
6486151 N-oxides of heterocyclic esters, amides, thioesters, and ketonesApr 26, 01Nov 26, 02GLIAMED, INC., GPI NIL HOLDINGS, INC.,
6323346 Process for producing aziridine compoundsMar 09, 00Nov 27, 01Daicel Chemical Industries, Ltd.
4795627 Tritium labelled N-mustard type compounds and a process for their productionOct 18, 84Jan 03, 89UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION, STATE OF ISRAEL, INSTITUTE FOR BIOLOGICAL RESEARCH,
4321194 N-Substituted aziridine-2-carboxylic acid derivatives for immuno stimulationJul 23, 79Mar 23, 82Boehringer Mannheim GmbH